Personalized Medicine in Multiple Sclerosis: Ask the Experts Q&A, Part 1
neuroscienceCME Webcast
Premiere Date: Tuesday, July 17, 2012 | Fred D. Lublin, MD, FAAN, FANA Saunders Family Professor of Neurology Director, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis Icahn School of Medicine at Mount Sinai New York, NY |
 | Robert P. Lisak, MD, FAAN, FRCP Professor of Neurology Professor of Immunology and Microbiology Wayne State University School of Medicine Chief of Neurology Harper University Hospital Detroit, MI |
CME Outfitters conducted a satellite symposium entitled, Personalized Medicine in Multiple Sclerosis: Examining the Path Forward at the Consortium of Multiple Sclerosis Centers (CMSC) annual meeting on May 30, 2012. The activity was attended by over 300 physicians, nurses, and clinicians with an interest in multiple sclerosis. This live, interactive symposium was captured on video and will be available as a certified activity at www.neuroscienceCME.com/CMW703 on July 2, 2012.
Because the opportunity to engage and connect with faculty is critical to the translation of the data, three (3) live Q & A dates have been scheduled to Ask the Experts.
Join the faculty to ask questions, pose your clinical case challenges, and to hear their insights on emerging data as the field moves toward personalized medicine in the management of MS.
Please register in advance for these live Q & A sessions because we will be sending reminder e-mails and information prior to the events. Do not miss this opportunity to exchange your thoughts and questions with Drs. Lisak, Lublin, and Steinman!
This 30-minute Q & A session is not certified for CE credit.
CME Outfitters, LLC, gratefully acknowledge an educational grant from Biogen Idec in support of this activity.
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, and other health care professionals with an interest in multiple sclerosis
Disclosure of Relevant Financial Relationships with Commercial Interests
It is the policy of CME Outfitters, LLC, that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
CME Outfitters will identify, review, and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist between the following individuals and commercial interests:
Dr. Lublin has disclosed that he receives grants/research support from Acorda Therapeutics, Inc; Biogen Idec; Celgene Corporation, National Institutes of Health; National Multiple Sclerosis Society; Novartis Pharmaceuticals Corporation, sanofi-aventis US, LLC, and Teva Neurosciences, Inc. He serves as a consultant to Abbott Laboratories; Acorda Therapeutics, Actelion Pharmaceuticals Ltd; Allozyne Inc., AVANIR Pharmaceuticals Inc.; Bayer HealthCare Pharmaceuticals Inc.; Biogen Idec, Bristol-Myers Squibb; Celgene Corporation; Coronado Bioscience; EMD Serono, Inc; Genmab, Inc.; Genzyme Corporation; Johnson & Johnson Services, Inc.; Medicinova, Inc.; MedImmune, LLC; MorphoSys; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Questcor Pharmaceuticals, Inc.; Revalesio Corporation; Roche; sanofi-aventis US LLC; and Teva Neurosciences, Inc. He as disclosed a financial interest/stock ownership in Cognition Pharmaceuticals, Inc.
Dr. Lisak has disclosed that he receives grants/research support from AVANIR Pharmaceuticals Inc.; Biogen Idec, Genzyme Corporation; Novartis Pharmaceuticals Corporation; Questcor Pharmaceuticals, Inc.; and Teva Neurosciences, Inc. He has received honoraria/speakers fees from Questcor Pharmaceuticals, Inc. He serves as a consultant for Novartis Pharmaceuticals Corporation; Questcor Pharmaceuticals, Inc.; and Teva Neurosciences, Inc.
Sharon Tordoff, CCMEP (planning committee) has nothing to disclose.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has nothing to disclose.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
CME Outfitters, LLC, the faculty, and Biogen Idec do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
WC-018-071712-29
